Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Myovant Sciences Ltd. (MYOV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/10/2023 |
4
| Valente Nancy (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 36,892 options to buy
@ $22.71, valued at
$837.8k
|
|
| 03/10/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 45,000 options to buy
@ $26.17, valued at
$1.2M
Disposed/sold 58,608 options to buy
@ $7.65, valued at
$448.4k
Disposed/sold 21,603 options to buy
@ $21.47, valued at
$463.8k
Disposed/sold 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 03/10/2023 |
4
| Merendino Lauren (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 21,791 shares
@ $0
Disposed/sold 147,747 shares
@ $0
Disposed/sold 123,300 options to buy
@ $17.88, valued at
$2.2M
Disposed/sold 103,703 rights
@ $0 |
|
| 03/10/2023 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 20,724 shares
@ $0
Disposed/sold 181,972 shares
@ $0
Disposed/sold 165,192 options to buy
@ $21.83, valued at
$3.6M
Disposed/sold 111,111 rights
@ $0 |
|
| 03/10/2023 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 95,675 shares
@ $0
Disposed/sold 321,924 shares
@ $0
Disposed/sold 306,427 options to buy
@ $20.54, valued at
$6.3M
Disposed/sold 208,218 options to buy
@ $17.88, valued at
$3.7M
Disposed/sold 204,808 options to buy
@ $11.33, valued at
$2.3M
Disposed/sold 134,567 rights
@ $0 |
|
| 03/10/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 113,145 shares
@ $0
Disposed/sold 241,158 shares
@ $0
Disposed/sold 220,000 options to buy
@ $7.78, valued at
$1.7M
Disposed/sold 87,050 options to buy
@ $7.78, valued at
$677.2k
Disposed/sold 152,110 options to buy
@ $7.78, valued at
$1.2M
Disposed/sold 170,396 options to buy
@ $8.08, valued at
$1.4M
Disposed/sold 90,310 options to buy
@ $17.88, valued at
$1.6M
Disposed/sold 111,111 rights
@ $0 |
|
| 03/10/2023 |
4
| Gulfo Adele M. (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 45,000 options to buy
@ $11.17, valued at
$502.7k
Disposed/sold 21,603 options to buy
@ $21.47, valued at
$463.8k
Disposed/sold 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 03/10/2023 |
4
| GUINAN MARK (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 45,000 options to buy
@ $19.71, valued at
$887k
Disposed/sold 58,608 options to buy
@ $7.65, valued at
$448.4k
Disposed/sold 21,603 options to buy
@ $21.47, valued at
$463.8k
Disposed/sold 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 03/10/2023 |
4
| Curran Terrie (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 33,846 options to buy
@ $11.3, valued at
$382.5k
Disposed/sold 11,154 options to buy
@ $12.68, valued at
$141.4k
Disposed/sold 22,500 options to buy
@ $13.14, valued at
$295.7k
Disposed/sold 22,500 options to buy
@ $24.25, valued at
$545.6k
Disposed/sold 5,250 options to buy
@ $7.65, valued at
$40.2k
Disposed/sold 21,603 options to buy
@ $21.47, valued at
$463.8k
Disposed/sold 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 03/10/2023 |
4
| Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 86,602 shares
@ $0
Disposed/sold 160,082 shares
@ $0
Disposed/sold 155,300 options to buy
@ $7.78, valued at
$1.2M
Disposed/sold 63,717 options to buy
@ $7.78, valued at
$495.7k
Disposed/sold 65,863 options to buy
@ $7.78, valued at
$512.4k
Disposed/sold 134,464 options to buy
@ $8.08, valued at
$1.1M
Disposed/sold 79,472 options to buy
@ $17.88, valued at
$1.4M
Disposed/sold 103,703 rights
@ $0 |
|
| 03/10/2023 |
4
| Sumitomo Chemical Co., Ltd. (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Bought 51,599,200 shares
@ $27, valued at
$1393.2M
|
|
| 03/06/2023 |
4
| Sumitomo Chemical Co., Ltd. (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed of 4,243,005 shares
@ $0
Acquired 1 options to buy
@ $27, valued at
$27 |
|
| 01/20/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 1,272 shares
@ $26.89, valued at
$34.2k
|
|
| 01/20/2023 |
4
| Merendino Lauren (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,008 shares
@ $26.89, valued at
$54k
|
|
| 01/20/2023 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 8,037 shares
@ $26.89, valued at
$216.1k
|
|
| 01/20/2023 |
4
| Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 1,109 shares
@ $26.89, valued at
$29.8k
|
|
| 01/05/2023 |
4
| Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,251 shares
@ $26.9, valued at
$60.6k
|
|
| 01/05/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,779 shares
@ $26.9, valued at
$74.8k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Curran Terrie (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 9,859 shares
@ $0 |
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 9,243 shares
@ $18.86, valued at
$174.3k
|
|
| 08/16/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 124,780 shares
@ $0
Sold 31,214 shares
@ $18.23, valued at
$569k
|
|
| 07/20/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 1,935 shares
@ $12.87, valued at
$24.9k
|
|
|
|
|